Find trials
Search tips

Screening for PPCM Using AI

Overview

About this study

The overall goal of this study is to investigate the use of artificial intelligence (AI) techniques as a screening tool for cardiomyopathies in pregnancy and the post-partum period.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women of reproductive age, 18 – 49 years.
  • Seen for clinical care by an obstetrician/gynecologist or cardiologist; advanced practice nurse or physician assistant working in the selected practice.

Exclusion Criteria:  

  • Complex congenital heart disease (single ventricle physiology, complex cardiac surgery or significant shunts with cardiac structural changes).
  • Significant conduction abnormalities.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Peter Noseworthy, M.D., M.B.A.

Closed for enrollment

Contact information:

Andrea Morales Lara M.D.

(904) 953-5070

MoralesLara.Andrea@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Demilade Adedinsewo, M.B., Ch.B.

Closed for enrollment

Contact information:

Andrea Morales Lara M.D.

(904) 953-5070

MoralesLara.Andrea@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20518325

Mayo Clinic Footer